A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 607,750 shares of KOD stock, worth $3.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
607,750
Previous 708,800 14.26%
Holding current value
$3.76 Million
Previous $1.67 Million 4.74%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$2.2 - $3.25 $222,310 - $328,412
-101,050 Reduced 14.26%
607,750 $1.59 Million
Q2 2024

Aug 09, 2024

BUY
$2.29 - $4.48 $291,746 - $570,752
127,400 Added 21.91%
708,800 $1.67 Million
Q1 2024

May 13, 2024

SELL
$3.01 - $7.45 $117,085 - $289,797
-38,899 Reduced 6.27%
581,400 $3.06 Million
Q4 2023

Feb 13, 2024

SELL
$1.4 - $3.24 $241,684 - $559,327
-172,632 Reduced 21.77%
620,299 $1.89 Million
Q3 2023

Nov 14, 2023

BUY
$1.8 - $7.49 $690,175 - $2.87 Million
383,431 Added 93.63%
792,931 $1.43 Million
Q2 2023

Aug 11, 2023

BUY
$4.3 - $9.48 $337,550 - $744,180
78,500 Added 23.72%
409,500 $2.83 Million
Q1 2023

May 12, 2023

SELL
$4.81 - $8.88 $439,152 - $810,744
-91,300 Reduced 21.62%
331,000 $2.05 Million
Q4 2022

Feb 13, 2023

BUY
$6.52 - $8.05 $602,056 - $743,337
92,340 Added 27.99%
422,300 $3.02 Million
Q3 2022

Nov 14, 2022

BUY
$7.57 - $12.5 $1.11 Million - $1.83 Million
146,460 Added 79.81%
329,960 $2.55 Million
Q2 2022

Aug 12, 2022

BUY
$5.04 - $9.48 $924,840 - $1.74 Million
183,500 New
183,500 $1.4 Million
Q3 2021

Nov 12, 2021

SELL
$81.97 - $106.94 $3.61 Million - $4.72 Million
-44,100 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$77.2 - $126.54 $895,520 - $1.47 Million
11,600 Added 35.69%
44,100 $4.1 Million
Q1 2021

May 13, 2021

BUY
$110.45 - $164.47 $3.59 Million - $5.35 Million
32,500 New
32,500 $3.69 Million
Q2 2020

Aug 13, 2020

SELL
$42.74 - $66.25 $2.37 Million - $3.67 Million
-55,359 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$38.18 - $73.95 $9.32 Million - $18 Million
-244,000 Reduced 81.51%
55,359 $2.64 Million
Q4 2019

Feb 13, 2020

BUY
$13.9 - $76.65 $928,714 - $5.12 Million
66,814 Added 28.73%
299,359 $21.5 Million
Q3 2019

Nov 13, 2019

BUY
$10.24 - $17.57 $1.14 Million - $1.96 Million
111,331 Added 91.85%
232,545 $3.34 Million
Q2 2019

Aug 12, 2019

BUY
$6.2 - $12.0 $751,526 - $1.45 Million
121,214 New
121,214 $1.42 Million

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $322M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.